{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T00:45:28Z","timestamp":1790642728464,"version":"4.1.0"},"reference-count":25,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100007856","name":"Baylor College of Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007856","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009857","name":"Regeneron Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009857","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004328","name":"Genentech","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004328","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012782","name":"Ophthalmic Consultants of Boston","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012782","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology Retina"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.oret.2019.04.006","type":"journal-article","created":{"date-parts":[[2019,4,11]],"date-time":"2019-04-11T19:17:06Z","timestamp":1555010226000},"page":"753-759","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":62,"title":["Aflibercept-Related Sterile Intraocular Inflammation Outcomes"],"prefix":"10.1016","volume":"3","author":[{"given":"Jonathan P.","family":"Greenberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Belin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Butler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4158-4682","authenticated-orcid":false,"given":"Daniel","family":"Feiler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3203-0661","authenticated-orcid":false,"given":"Christian","family":"Mueller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Tye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven M.","family":"Friedlander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geoffrey G.","family":"Emerson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1748-4614","authenticated-orcid":false,"given":"Philip J.","family":"Ferrone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.oret.2019.04.006_bib1","first-page":"943409","article-title":"Vitreous inflammation associated with intravitreal anti-VEGF pharmacotherapy","author":"Agrawal","year":"2013","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.oret.2019.04.006_bib2","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1097\/IAE.0b013e3181dc04da","article-title":"Characterization of sterile intraocular inflammatory responses after intravitreal bevacizumab injection","volume":"30","author":"Chong","year":"2010","journal-title":"Retina"},{"key":"10.1016\/j.oret.2019.04.006_bib3","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.ophtha.2012.07.083","article-title":"Acute intraocular inflammation caused by endotoxin after intravitreal injection of counterfeit bevacizumab in Shanghai, China","volume":"120","author":"Wang","year":"2013","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2019.04.006_bib4","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1097\/IAE.0b013e3181baf691","article-title":"Toxic vitreitis outbreak after intravitreal injection","volume":"30","author":"Ness","year":"2010","journal-title":"Retina"},{"key":"10.1016\/j.oret.2019.04.006_bib5","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1097\/IAE.0b013e3181bd2d51","article-title":"Sterile endophthalmitis after intravitreal injection of bevacizumab obtained from a single batch","volume":"30","author":"Yamashiro","year":"2010","journal-title":"Retina"},{"key":"10.1016\/j.oret.2019.04.006_bib6","doi-asserted-by":"crossref","first-page":"41","DOI":"10.5693\/djo.01.2016.03.001","article-title":"A\u00a0cluster of presumed, noninfectious endophthalmitis after intravitreal injection of bevacizumab: long-term follow-up","volume":"22","author":"Ricci","year":"2016","journal-title":"Digit J Ophthalmol"},{"key":"10.1016\/j.oret.2019.04.006_bib7","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1097\/IAE.0000000000000801","article-title":"Noninfectious vitritis after intravitreal injection of anti-VEFG agents: variations in rates and presentation by medication","volume":"36","author":"Williams","year":"2016","journal-title":"Retina"},{"key":"10.1016\/j.oret.2019.04.006_bib8","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.ophtha.2017.07.005","article-title":"Incidence and outcomes of infectious and noninfectious endophthalmitis after intravitreal injections for age-related macular degeneration","volume":"125","author":"Daien","year":"2018","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2019.04.006_bib9","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/j.ophtha.2012.11.018","article-title":"Aflibercept-related sterile inflammation","volume":"120","author":"Hahn","year":"2013","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2019.04.006_bib10","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1001\/jamaophthalmol.2014.5650","article-title":"Postmarketing analysis of aflibercept-related sterile intraocular inflammation","volume":"133","author":"Hahn","year":"2015","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.oret.2019.04.006_bib11","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1097\/IAE.0000000000000398","article-title":"Frequency and characteristics of intraocular inflammation after aflibercept injection","volume":"35","author":"Fine","year":"2015","journal-title":"Retina"},{"key":"10.1016\/j.oret.2019.04.006_bib12","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.ajo.2014.06.019","article-title":"Noninfectious inflammation after intravitreal injection of aflibercept: clinical characteristics and visual outcomes","volume":"158","author":"Goldberg","year":"2014","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.oret.2019.04.006_bib13","doi-asserted-by":"crossref","first-page":"325","DOI":"10.3341\/kjo.2015.29.5.325","article-title":"Sterile inflammation after intravitreal injection of aflibercept in a Korean population","volume":"29","author":"Kim","year":"2015","journal-title":"Korean J Ophthalmol"},{"key":"10.1016\/j.oret.2019.04.006_bib14","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1136\/bjo.2007.132597","article-title":"Pegaptanib sodium for neovascular age-related macular degeneration: third-year safety results of the VEGF Inhibition Study in Ocular Neovascularisation (VISION) trial","volume":"92","author":"Singerman","year":"2008","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.oret.2019.04.006_bib15","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1001\/archopht.121.9.1279","article-title":"Noninfectious endophthalmitis associated with intravitreal triamcinolone injection","volume":"121","author":"Roth","year":"2003","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.oret.2019.04.006_bib16","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.ajo.2008.12.034","article-title":"Anatomic and visual outcomes of noninfectious endophthalmitis after intravitreal triamcinolone","volume":"147","author":"Yoon","year":"2009","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.oret.2019.04.006_bib17","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1007\/s00417-012-2111-8","article-title":"Associated factors and treatment outcome of presumed noninfectious endophthalmitis occurring after intravitreal triamcinolone acetonide injection","volume":"251","author":"Ahn","year":"2013","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.oret.2019.04.006_bib19","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1097\/ICB.0000000000000149","article-title":"Sterile endophthalmitis after intravitreal ocriplasmin injection: report of a single case","volume":"9","author":"Han","year":"2015","journal-title":"Retin Cases Brief Rep"},{"key":"10.1016\/j.oret.2019.04.006_bib21","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1001\/archopht.1995.01100120009001","article-title":"Results of the Endophthalmitis Vitrectomy Study. A randomized trial of immediate vitrectomy and of intravenous antibiotics for the treatment of postoperative bacterial endophthalmitis","volume":"113","year":"1995","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.oret.2019.04.006_bib22","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1038\/eye.2013.139","article-title":"Quality of bevacizumab compounded for intravitreal administration","volume":"27","author":"Palmer","year":"2013","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.oret.2019.04.006_bib23","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1167\/iovs.10-6431","article-title":"Silicone oil microdroplets and protein aggregates in repackaged bevacizumab and ranibizumab: effects of long-term storage and product mishandling","volume":"22","author":"Liu","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.oret.2019.04.006_bib24","doi-asserted-by":"crossref","first-page":"643","DOI":"10.3928\/23258160-20150610-08","article-title":"Current infectious endophthalmitis rates after intravitreal injections of anti-vascular endothelial growth factor agents and outcomes of treatment","volume":"46","author":"Gregori","year":"2015","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"key":"10.1016\/j.oret.2019.04.006_bib25","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1097\/IAE.0b013e31821067c4","article-title":"Endophthalmitis after intravitreal vascular [corrected] endothelial growth factor antagonists: a six-year experience at a university referral center","volume":"31","author":"Moshfeghi","year":"2011","journal-title":"Retina"},{"key":"10.1016\/j.oret.2019.04.006_bib26","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1016\/j.ophtha.2011.02.034","article-title":"Outcomes and risk factors associated with endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor agents","volume":"118","author":"Shah","year":"2011","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2019.04.006_bib27","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1097\/IAE.0b013e3181cd47ed","article-title":"Clinical characteristics of endophthalmitis after an injection of intravitreal anti-vascular endothelial growth factor","volume":"30","author":"Mezad-Koursh","year":"2010","journal-title":"Retina"}],"container-title":["Ophthalmology Retina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468653018306997?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468653018306997?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T09:26:03Z","timestamp":1762853163000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468653018306997"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":25,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["S2468653018306997"],"URL":"https:\/\/doi.org\/10.1016\/j.oret.2019.04.006","relation":{},"ISSN":["2468-6530"],"issn-type":[{"value":"2468-6530","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Aflibercept-Related Sterile Intraocular Inflammation Outcomes","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology Retina","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.oret.2019.04.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 by the American Academy of Ophthalmology","name":"copyright","label":"Copyright"}]}}